Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2109871Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Psychiatry
NIH Funding · FY2025
Linked Award Amount
$1.1M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#15,405
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Carol A Tamminga as a PI. Multi-PI records show the full award amount for context.
- 5R01MH123479-05R01Reverse Translation of Psychosis - associated Hippocampal Hyperactivity in the mouse$410Kaward amount
- 5R01MH124813-05R011/5 - Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)$369Kaward amount
- 5R01MH127179-04R011/5 - Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)$287Kaward amount
Award organization
Organizations that administered FY2025 awards listing Carol A Tamminga as a PI.
FY2025 award administered by UT Southwestern Medical Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT Southwestern Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024R01 Grant Holder
- 2025$2M Cumulative Funding